Phreesia Total Liabilities and Share Holders Equity 2019-2024 | PHR

Phreesia total liabilities and share holders equity from 2019 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Phreesia Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $370
2023 $370
2022 $494
2021 $327
2020 $159
2019 $59
2018 $0
Phreesia Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-10-31 $376
2024-07-31 $362
2024-04-30 $372
2024-01-31 $370
2023-10-31 $375
2023-07-31 $340
2023-04-30 $354
2023-01-31 $370
2022-10-31 $397
2022-07-31 $426
2022-04-30 $459
2022-01-31 $494
2021-10-31 $529
2021-07-31 $551
2021-04-30 $561
2021-01-31 $327
2020-10-31 $338
2020-07-31 $160
2020-04-30 $161
2020-01-31 $159
2019-10-31 $156
2019-07-31 $163
2019-04-30 $0
2019-01-31
2018-10-31 $0
2018-07-31 $0
2018-01-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.669B $0.356B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.714B 55.57
Tempus AI (TEM) United States $7.994B 0.00
Hims & Hers Health (HIMS) United States $6.961B 177.00
Inspire Medical Systems (INSP) United States $5.693B 177.56
IRhythm Technologies (IRTC) United States $3.453B 0.00
Privia Health (PRVA) United States $2.701B 225.10
Enovis (ENOV) United States $2.693B 17.94
Azenta (AZTA) United States $2.440B 130.24
Clover Health Investments (CLOV) United States $2.230B 0.00
Omnicell (OMCL) United States $2.070B 67.71
Schrodinger (SDGR) United States $1.819B 0.00
10x Genomics (TXG) United States $1.796B 0.00
Butterfly Network (BFLY) United States $0.748B 0.00
Standard BioTools (LAB) United States $0.588B 0.00
Talkspace (TALK) United States $0.537B 0.00
Fulgent Genetics (FLGT) United States $0.515B 0.00
TruBridge (TBRG) United States $0.362B 105.43
Nyxoah SA (NYXH) Belgium $0.354B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Pulmonx (LUNG) United States $0.230B 0.00
American Well (AMWL) United States $0.169B 0.00
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
P3 Health Partners (PIII) United States $0.069B 0.00
CareCloud (CCLD) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
111 (YI) China $0.047B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00